Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Abstract
Orphan Drug Designations in Ophthalmology
William C. Stewart, Shilla Marie Hernandez, Jeanette A. Stewart and Lindsay A. Nelson
Purpose: To evaluate orphan drug designations within ophthalmology since passage of the Orphan Drug Act and their ultimate availability and utility to the ophthalmic community.
Methods: The study design was a retrospective, observational review of orphan drug designations in ophthalmology.
Results: We identified 72 new ophthalmic drugs that received an orphan drug designation, of which four received NDA approval and all became commercially available, three for ocular and one for systemic indications.
Conclusions: This study suggests a low rate of commercialization of new ocular pharmaceutical agents with an orphan designation being approved for the original indication.
Published Date: 2018-05-15; Received Date: 2018-04-25